Developing a COVID-19 mortality risk prediction model when individual-level data are not available
Identification of individuals at risk of severe COVID-19 disease could inform treatment and public health planning. Here, the authors develop and validate a risk prediction model for COVID-19 mortality in Israel by building a model for severe respiratory infection and recalibrating it using COVID-19...
Main Authors: | Noam Barda, Dan Riesel, Amichay Akriv, Joseph Levy, Uriah Finkel, Gal Yona, Daniel Greenfeld, Shimon Sheiba, Jonathan Somer, Eitan Bachmat, Guy N. Rothblum, Uri Shalit, Doron Netzer, Ran Balicer, Noa Dagan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18297-9 |
Similar Items
-
On the Arakelov Chow group of arithmetic abelian schemes and other spaces with symmetries
by: Bachmat, Eitan
Published: (2005) -
Size-Based Routing Policies: Non-Asymptotic Analysis and Design of Decentralized Systems
by: Eitan Bachmat, et al.
Published: (2021-04-01) -
Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel
by: Balicer, R.D, et al.
Published: (2022) -
The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines
by: Barda, N., et al.
Published: (2022) -
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting
by: Balicer, R., et al.
Published: (2022)